Athersys
ATHX
#11224
Rank
S$1.06 M
Marketcap
S$0.01729
Share price
-33.50%
Change (1 day)
-98.92%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -S$56.26 Million

According to Athersys's latest financial reports the company's current earnings are S$0.08 Million. In 2022 the company made an earning of -S$98.61 Million, an increase over its 2021 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$56.26 Million-42.95%
2022 -S$98.61 Million-11.54%
2021 -S$0.12 Billion11.14%
2020 -S$0.11 Billion72.2%
2019 -S$58.25 Million77.29%
2018 -S$32.86 Million-22.91%
2017 -S$42.62 Million111.89%
2016 -S$20.12 Million-8.52%
2015 -S$21.99 Million-40.81%
2014 -S$37.15 Million18.62%
2013 -S$31.32 Million
2011 -S$17.65 Million19.71%
2010 -S$14.74 Million-26.28%
2009 -S$20 Million-18.21%
2008 -S$24.45 Million-8.28%
2007 -S$26.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B-62,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.84 B-16,638.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.17 B-24,732.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.16 B-17,245.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$9.84 B-18,513.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.24 B-28,618.75%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
S$0.22 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$3.9 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.81 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA